Joint EMA/EORTC Workshop

Amsterdam, NL (Hybrid Event)

The European Medicines Agency (EMA) and the European Organisation for Research and Treatment of Cancer (EORTC) are jointly organising a workshop called “How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions?

This workshop will bring together international experts from academia, learned societies, patients, regulatory agencies, health technology assessment bodies, and industry.

Date: Thursday, 29 February 2024
Location: European Medicines Agency, Amsterdam

Next events

  • EORTC Brain Tumour Group Spring Meeting

    Brussels, Belgium (hybrid)

  • EORTC Soft Tissue and Bone Sarcoma Group Spring Meeting

    Lugano, CH

  • EORTC Gastrointestinal Tract Cancer Group Spring Meeting

    Brussels, BE

  • EORTC Lymphoma Group Spring Meeting

    Zagreb, Croatia

  • 14th European Breast Cancer Conference (EBCC-14)

    Milan, Italy